ASTM Pharmaceutical Committee Joins FDA and CDER in Joint Workshop
On October 12, members of the Committee on Manufacture of Pharmaceutical and Biopharmaceutical Products attended the U.S. Food and Drug Administration (FDA) / (Center for Drug Evaluation and Research (CDER) / ASTM Workshop on Standards for Pharmaceutical Products. Building on the relationship between ASTM Committee E55 and the FDA, the workshop showcased the ongoing work of the committee as well as topic-specific observations from FDA research as it relates to existing E55 standards.
Pictured from left to right are: Graham Cook (Pfizer, E55 Chairman); Rapti Madurawe (FDA, workshop Panelist); Kurt Brorson (FDA, workshop panelist); Duncan Low (Amgen, E55 member, workshop panelist); Bob Steininger (E55 member, workshop panelist); Pallavi Nithyanandan (FDA, E55 member); Cindy Buhse (FDA, workshop panelist); Larry Lee (FDA, workshop panelist); Travis Murdock (E55 Staff Manager).
SN Home
Archive
Advertisers
Masthead
RateCard
Subscribe
Email Editor